| 股东 | |||
|---|---|---|---|
| WANG QINGHUA本公司董事长兼总经理 · 执行董事 | 28.86% | 1.21 亿 | |
| Hong Kong Invengen Pharmaceutical Technology Co., Limited | 28.56% | 1.21 亿 | |
| Shanghai Nuotang Biotechnology Co., Ltd. | 12.44% | 5,229.98 万 | |
| KOREA INVESTMENT HOLDINGS Co., Ltd. | 7.79% | 3,275.26 万 | |
| Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership) | 6.24% | 2,621.97 万 | |
| Fullerton Fund Investments Pte Ltd | 6.03% | 2,534.49 万 | |
| 景得(广州)股权投资合伙企业(有限合伙) | 5.61% | 2,355.64 万 | |
| Guangzhou Nuosu Enterprise Management Partnership (Limited Partnership) | 5.51% | 2,316.81 万 | |
| 广州市人民政府国有资产监督管理委员会 | 5.38% | 2,259.48 万 |
持有 5% 或以上有投票权股份的股东(好仓),来自港交所披露易权益披露《大股东综合名单》;报告日期为该股东最后一次申报日期。
| 股东 | 交易价格 | 交易类型 | 持仓比例 | ||||
|---|---|---|---|---|---|---|---|
| 郑伟鹤 | -519.00 万 | 3.82 | 卖出 | 1,960.11 万 | 4.66% | ||
| 黄荔 | -519.00 万 | 3.82 | 卖出 | 1,960.11 万 | 4.66% | ||
| Cowin China Growth Fund II, L.P. | -399.00 万 | 3.82 | 卖出 | 1,042.64 万 | 2.48% | ||
| Cowin Capital Investment III Limited | -399.00 万 | 3.82 | 卖出 | 1,042.64 万 | 2.48% | ||
| Cowin Capital Investment II LTD | -399.00 万 | 3.82 | 卖出 | 1,042.64 万 | 2.48% | ||
| Cowin Capital Investment Limited | -399.00 万 | 3.82 | 卖出 | 1,042.64 万 | 2.48% | ||
| 黄荔 | -440.00 万 | 3.61 | 卖出 | 2,479.11 万 | 5.90% | ||
| 郑伟鹤 | -440.00 万 | 3.61 | 卖出 | 2,479.11 万 | 5.90% | ||
| Cowin Capital Investment Limited | -337.00 万 | 3.61 | 卖出 | 1,441.64 万 | 3.43% | ||
| Cowin Capital Investment II LTD | -337.00 万 | 3.61 | 卖出 | 1,441.64 万 | 3.43% | ||
| Cowin Capital Investment III Limited | -337.00 万 | 3.61 | 卖出 | 1,441.64 万 | 3.43% | ||
| Cowin China Growth Fund II, L.P. | -337.00 万 | 3.61 | 卖出 | 1,441.64 万 | 3.43% | ||
| 郑伟鹤 | -375.00 万 | 3.64 | 卖出 | 2,919.11 万 | 6.95% | ||
| 黄荔 | -375.00 万 | 3.64 | 卖出 | 2,919.11 万 | 6.95% | ||
| Cowin China Growth Fund II, L.P. | -287.00 万 | 3.64 | 卖出 | 1,778.64 万 | 4.23% | ||
| Cowin Capital Investment III Limited | -287.00 万 | 3.64 | 卖出 | 1,778.64 万 | 4.23% | ||
| Cowin Capital Investment II LTD | -287.00 万 | 3.64 | 卖出 | 1,778.64 万 | 4.23% | ||
| Cowin Capital Investment Limited | -287.00 万 | 3.64 | 卖出 | 1,778.64 万 | 4.23% | ||
| Pavilion Capital Holdings Pte. Ltd. | 117.30 万 | 3.84 | 不再持有须具报权益 | 1,996.19 万 | 4.75% | ||
| Pavilion Capital GP Pte. Ltd. | 117.30 万 | 3.84 | 不再持有须具报权益 | 1,996.19 万 | 4.75% | ||
| PavCap I Feeder No. 1 LP | 117.30 万 | 3.84 | 不再持有须具报权益 | 1,996.19 万 | 4.75% | ||
| PavCap Fund I | 117.30 万 | 3.84 | 不再持有须具报权益 | 1,996.19 万 | 4.75% | ||
| Palace Investments Pte. Ltd. | 117.30 万 | 3.84 | 不再持有须具报权益 | 1,996.19 万 | 4.75% | ||
| Temasek Holdings (Private) Limited | 117.30 万 | 3.84 | 不再持有须具报权益 | 1,996.19 万 | 4.75% | ||
| 黄荔 | -455.00 万 | 4.00 | 卖出 | 3,294.11 万 | 7.84% | ||
| 郑伟鹤 | -455.00 万 | 4.00 | 卖出 | 3,294.11 万 | 7.84% | ||
| Cowin Capital Investment Limited | -350.00 万 | 4.00 | 卖出 | 2,065.64 万 | 4.91% | ||
| Cowin Capital Investment II LTD | -350.00 万 | 4.00 | 卖出 | 2,065.64 万 | 4.91% | ||
| Cowin Capital Investment III Limited | -350.00 万 | 4.00 | 卖出 | 2,065.64 万 | 4.91% | ||
| Cowin China Growth Fund II, L.P. | -350.00 万 | 4.00 | 卖出 | 2,065.64 万 | 4.91% | ||
| 韩投伙伴(上海)创业投资管理有限责任公司 | -392.14 万 | 4.15 | 卖出 | 3,275.26 万 | 7.79% | ||
| KOREA INVESTMENT PARTNERS Co., Ltd. | -392.14 万 | 4.15 | 卖出 | 3,275.26 万 | 7.79% | ||
| KOREA INVESTMENT HOLDINGS Co., Ltd. | -392.14 万 | 4.15 | 卖出 | 3,275.26 万 | 7.79% | ||
| KOREA INVESTMENT PARTNERS Co., Ltd. | -392.14 万 | 4.15 | 卖出 | 3,275.26 万 | 7.79% | ||
| 韩投伙伴(上海)创业投资管理有限责任公司 | -392.14 万 | 4.15 | 卖出 | 3,275.26 万 | 7.79% | ||
| 郑伟鹤 | -112.00 万 | 4.34 | 卖出 | 3,749.11 万 | 8.92% | ||
| 黄荔 | -112.00 万 | 4.34 | 卖出 | 3,749.11 万 | 8.92% | ||
| Cowin China Growth Fund II, L.P. | -86.00 万 | 4.34 | 卖出 | 2,415.64 万 | 5.75% | ||
| Cowin Capital Investment III Limited | -86.00 万 | 4.34 | 卖出 | 2,415.64 万 | 5.75% | ||
| Cowin Capital Investment II LTD | -86.00 万 | 4.34 | 卖出 | 2,415.64 万 | 5.75% | ||
| Cowin Capital Investment Limited | -86.00 万 | 4.34 | 卖出 | 2,415.64 万 | 5.75% | ||
| 黄荔 | -201.00 万 | 4.45 | 卖出 | 3,861.11 万 | 9.19% | ||
| 郑伟鹤 | -201.00 万 | 4.45 | 卖出 | 3,861.11 万 | 9.19% | ||
| Temasek Holdings (Private) Limited | -180.88 万 | 4.94 | 卖出 | 2,353.61 万 | 5.60% | ||
| Cowin Capital Investment Limited | -154.00 万 | 4.45 | 卖出 | 2,501.64 万 | 5.95% | ||
| Cowin Capital Investment II LTD | -154.00 万 | 4.45 | 卖出 | 2,501.64 万 | 5.95% | ||
| Cowin Capital Investment III Limited | -154.00 万 | 4.45 | 卖出 | 2,501.64 万 | 5.95% | ||
| Cowin China Growth Fund II, L.P. | -154.00 万 | 4.45 | 卖出 | 2,501.64 万 | 5.95% | ||
| 黄荔 | -335.00 万 | 5.03 | 卖出 | 4,062.11 万 | 9.67% | ||
| 郑伟鹤 | -335.00 万 | 5.03 | 卖出 | 4,062.11 万 | 9.67% | ||
| 韩投伙伴(上海)创业投资管理有限责任公司 | -505.76 万 | 5.08 | 卖出 | 3,667.40 万 | 8.73% | ||
| 景得(广州)股权投资合伙企业(有限合伙) | -300.00 万 | 5.09 | 卖出 | 2,355.64 万 | 5.61% | ||
| KIP KIS SEA-CHINA Fund | -300.00 万 | 5.09 | 卖出 | 2,355.64 万 | 5.61% | ||
| KOREA INVESTMENT PARTNERS Co., Ltd. | -505.76 万 | 5.08 | 卖出 | 3,667.40 万 | 8.73% | ||
| KOREA INVESTMENT & SECURITIES Co., Ltd | -300.00 万 | 5.09 | 卖出 | 2,355.64 万 | 5.61% | ||
| KOREA INVESTMENT HOLDINGS Co., Ltd. | -505.76 万 | 5.08 | 卖出 | 3,667.40 万 | 8.73% | ||
| Cowin China Growth Fund II, L.P. | -0 | -- | 卖出 | 2,655.64 万 | 6.32% | ||
| Cowin Capital Investment III Limited | -0 | -- | 卖出 | 2,655.64 万 | 6.32% | ||
| Cowin Capital Investment II LTD | -0 | -- | 卖出 | 2,655.64 万 | 6.32% | ||
| Cowin Capital Investment Limited | -0 | -- | 卖出 | 2,655.64 万 | 6.32% |
本页展示 银诺医药-B(02591)持股 5% 或以上的主要股东及其持股比例、持股数量与最后申报日期,以及近一年大股东的权益披露变动。数据来源于港交所披露易权益披露(DI)栏目。

